AR054525A1 - Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo - Google Patents
Composiciones y metodos para eltratamiento de sintomas relacionados con el cicloInfo
- Publication number
- AR054525A1 AR054525A1 ARP060102786A ARP060102786A AR054525A1 AR 054525 A1 AR054525 A1 AR 054525A1 AR P060102786 A ARP060102786 A AR P060102786A AR P060102786 A ARP060102786 A AR P060102786A AR 054525 A1 AR054525 A1 AR 054525A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- cycle
- compositions
- processing
- symptoms related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Métodos para tratar síntomas relacionados con el ciclo mediante la administracion de al menos una progestina y al menos un estrogeno a un individuo femenino, administrados diariamente por al menos 100 días.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69507705P | 2005-06-28 | 2005-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054525A1 true AR054525A1 (es) | 2007-06-27 |
Family
ID=37440889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060102786A AR054525A1 (es) | 2005-06-28 | 2006-06-28 | Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070009594A1 (es) |
EP (1) | EP1896037A2 (es) |
JP (1) | JP2008544989A (es) |
KR (1) | KR20080017061A (es) |
CN (1) | CN101252937A (es) |
AR (1) | AR054525A1 (es) |
AU (1) | AU2006263542A1 (es) |
BR (1) | BRPI0613021A2 (es) |
CA (1) | CA2612885A1 (es) |
CR (1) | CR9601A (es) |
EC (1) | ECSP078066A (es) |
GT (1) | GT200600280A (es) |
IL (1) | IL188237A0 (es) |
MX (1) | MX2007016364A (es) |
NO (1) | NO20080024L (es) |
PE (1) | PE20070327A1 (es) |
RU (1) | RU2007148080A (es) |
TW (1) | TW200726473A (es) |
WO (1) | WO2007002862A2 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
DE102007011486A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Arzneimittel umfassend wenigstens ein Gestagen |
EP2488159A2 (en) * | 2009-10-12 | 2012-08-22 | Lyka Labs Limited | Emergency contraceptive |
UY33103A (es) * | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
WO2012129812A1 (zh) * | 2011-03-31 | 2012-10-04 | 深圳市康泰尔电子有限公司 | 电子香烟 |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
DE102019115343A1 (de) * | 2019-06-06 | 2020-12-10 | EVESTRA GmbH | Vaginalring für die hormonelle Kontrazeption |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
JPS60174716A (ja) * | 1984-02-21 | 1985-09-09 | Yamanouchi Pharmaceut Co Ltd | パツチ剤 |
US4752478A (en) * | 1984-12-17 | 1988-06-21 | Merck & Co., Inc. | Transdermal system for timolol |
DE19705229C2 (de) * | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
EP1453521B1 (en) * | 2001-12-05 | 2013-09-04 | Teva Women's Health, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
AU2004257772B2 (en) * | 2003-07-16 | 2009-12-17 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
AU2005249401A1 (en) * | 2004-05-26 | 2005-12-15 | Wyeth | Compositions and methods for treatment of premenstrual dysphoric disorder |
-
2006
- 2006-06-21 TW TW095122320A patent/TW200726473A/zh unknown
- 2006-06-26 US US11/475,486 patent/US20070009594A1/en not_active Abandoned
- 2006-06-27 EP EP06774301A patent/EP1896037A2/en not_active Withdrawn
- 2006-06-27 WO PCT/US2006/025449 patent/WO2007002862A2/en active Application Filing
- 2006-06-27 CN CNA2006800316370A patent/CN101252937A/zh active Pending
- 2006-06-27 RU RU2007148080/14A patent/RU2007148080A/ru not_active Application Discontinuation
- 2006-06-27 MX MX2007016364A patent/MX2007016364A/es not_active Application Discontinuation
- 2006-06-27 JP JP2008519582A patent/JP2008544989A/ja active Pending
- 2006-06-27 AU AU2006263542A patent/AU2006263542A1/en not_active Abandoned
- 2006-06-27 CA CA002612885A patent/CA2612885A1/en not_active Abandoned
- 2006-06-27 KR KR1020077030684A patent/KR20080017061A/ko not_active Application Discontinuation
- 2006-06-27 BR BRPI0613021-6A patent/BRPI0613021A2/pt not_active Application Discontinuation
- 2006-06-28 PE PE2006000760A patent/PE20070327A1/es not_active Application Discontinuation
- 2006-06-28 GT GT200600280A patent/GT200600280A/es unknown
- 2006-06-28 AR ARP060102786A patent/AR054525A1/es not_active Application Discontinuation
-
2007
- 2007-12-18 CR CR9601A patent/CR9601A/es not_active Application Discontinuation
- 2007-12-19 IL IL188237A patent/IL188237A0/en unknown
- 2007-12-28 EC EC2007008066A patent/ECSP078066A/es unknown
-
2008
- 2008-01-03 NO NO20080024A patent/NO20080024L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20070009594A1 (en) | 2007-01-11 |
NO20080024L (no) | 2008-03-27 |
GT200600280A (es) | 2007-02-26 |
WO2007002862A2 (en) | 2007-01-04 |
KR20080017061A (ko) | 2008-02-25 |
IL188237A0 (en) | 2008-06-05 |
CR9601A (es) | 2008-05-05 |
TW200726473A (en) | 2007-07-16 |
RU2007148080A (ru) | 2009-08-10 |
AU2006263542A1 (en) | 2007-01-04 |
CN101252937A (zh) | 2008-08-27 |
PE20070327A1 (es) | 2007-05-04 |
WO2007002862A3 (en) | 2007-02-22 |
CA2612885A1 (en) | 2007-01-04 |
BRPI0613021A2 (pt) | 2010-12-14 |
JP2008544989A (ja) | 2008-12-11 |
ECSP078066A (es) | 2008-01-23 |
MX2007016364A (es) | 2008-03-05 |
EP1896037A2 (en) | 2008-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR054525A1 (es) | Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo | |
ECSP088123A (es) | Anticoncepcion oral con trimegestona | |
BRPI0509184A (pt) | composições farmacêuticas | |
AR050717A1 (es) | Composiciones farmaceuticas | |
EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
TW200637614A (en) | Bendamustine pharmaceutical compositions | |
CO6400186A2 (es) | Tabletas de acetato de ulipristal | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
EA200802324A1 (ru) | Новая форма введения рацекадотрила | |
MX2010006204A (es) | Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
DOP2010000302A (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida | |
TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
SE0501903L (sv) | Borföreningar användbara vid BNCT | |
SI1831239T1 (sl) | Postopek za pripravo gamma laktona hidroksi beta beta beta beta bismetilen alfa pregn en on karboksilne kisline in ključniintermediati za ta postopek | |
ME00955B (me) | Kompozicija sa produženim oslobađanjem koja sadrži derivat somatostatina u mikročesticama | |
BRPI0509014A (pt) | comprimidos desintegráveis que compreendem licarbazepina | |
BRPI0509667A (pt) | azaquinazolinas substituìdas com eficácia antiviral | |
EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
CO6400226A2 (es) | Micrólido anti-inflamatorio | |
ECSP088472A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
EA200970816A1 (ru) | Новая лекарственная форма | |
MX2010000120A (es) | Estereoisomeros de triciclodecan-9-il-xantogenato. | |
GT200500364A (es) | Nueva composicion farmaceutica que contiene por lo menos un derivado de dolastatina-10 | |
BRPI0507985A (pt) | derivados de piperazina uréia para o tratamento de endometriose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |